Market Cap 961.04M
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 10.20
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 5,632,500
Avg Vol 6,569,808
Day's Range N/A - N/A
Shares Out 160.84M
Stochastic %K 10%
Beta 3.21
Analysts Sell
Price Target $15.57

Latest News on NVAX

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

May 8, 2025, 1:31 PM EDT - 5 days ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why


Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:48 AM EDT - 5 days ago

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript


Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

May 8, 2025, 11:12 AM EDT - 5 days ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%


New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 6 days ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA PFE GSK IBB SRPT XBI


Novavax Appoints Charles Newton to Board of Directors

Apr 29, 2025, 8:00 AM EDT - 14 days ago

Novavax Appoints Charles Newton to Board of Directors


Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

Apr 23, 2025, 5:00 PM EDT - 20 days ago

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps


Vaccine stocks fall following FDA resignation

Mar 31, 2025, 6:21 PM EDT - 6 weeks ago

Vaccine stocks fall following FDA resignation

BNTX MRNA PFE PCVX PTCT XBI


Novavax Announces Changes to Board of Directors

Mar 11, 2025, 8:00 AM EDT - 2 months ago

Novavax Announces Changes to Board of Directors


Novavax to Participate in Upcoming March Investor Conferences

Feb 27, 2025, 4:05 PM EST - 2 months ago

Novavax to Participate in Upcoming March Investor Conferences


Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:42 AM EST - 2 months ago

Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript


Novavax Stock Is Rising. Revenue Beat Estimates.

Feb 27, 2025, 8:05 AM EST - 2 months ago

Novavax Stock Is Rising. Revenue Beat Estimates.